GSK va acquérir la société biopharmaceutique bostonienne IDRx pour un montant pouvant atteindre 1,15 milliard de dollars
Read the full article here:
Read the full article here:
Read the full article here:
Read the full article here:
Read the full article here:
Read the full article here:
Read the full article here:
Read the full article here: